Limiting Dilution Analysis of Specific in Vitro Anti-herpes Simplex Virus Antibody Production by Human Lymphocytes

Overview

Journal Clin Exp Immunol

Publisher Oxford University Press

Specialty Allergy & Immunology

Date 1987 Apr 1

PMID 2820632

Authors

M Yasukawa

Y Kobayashi

Affiliations

Soon will be listed here.

Abstract

An enzyme linked immunosorbent assay (ELISA) system to study specific anti-herpes simplex virus (HSV) antibody production in vitro by human peripheral blood mononuclear cells (PBMC) has been developed. HSV specific antibody production was detected in culture supernatants of PBMC from HSV seropositive healthy individuals by stimulating with optimal concentrations of HSV antigen without mitogens. To investigate the specificity of the resulting antibody, a limiting dilution analysis was performed as follows. PBMC from HSV-1 seropositive and HSV-2 seronegative individuals were stimulated by wild type HSV-1 (KOS), glycoprotein C deletion mutant of HSV-1 (MP), and wild type HSV-2 (186), and the precursor frequencies of B cells which produce antibodies to HSV-1 (KOS), HSV-1 (MP) and HSV-2 (186) were then estimated. When PBMC from five individuals were stimulated by HSV-1 (KOS), the estimated precursor frequencies of B cells which produced antibodies to HSV-1 (KOS), HSV-1 (MP), and HSV-2 (186) were 1/79,000 to 1/37,000, 1/104,000 to 1/52,000. and 1/78,000 to 1/101,000, respectively. On the other hand, when PBMC were stimulated by HSV-1 (MP) and HSV-2 (186), the precursor frequencies of B cells which produced antibody to HSV-1 (KOS) were the same as those to HSV-1 (MP) and HSV-2 (186), respectively. By using the experimental systems reported here, it became possible to determine clearly the immune status to HSV type-specific and type-common antigens and to each viral glycoprotein.

References

Rawls W, Laurel D, Melnick J, Glicksman J, Kaufman R . A search for viruses in smegma, premalignant and early malignant cervical tissues. The isolation of Herpesviruses with distinct antigenic properties. Am J Epidemiol. 1968; 87(3):647-55. DOI: 10.1093/oxfordjournals.aje.a120855. View

Spear P, Roizman B . Proteins specified by herpes simplex virus. V. Purification and structural proteins of the herpesvirion. J Virol. 1972; 9(1):143-59. PMC: 356272. DOI: 10.1128/JVI.9.1.143-159.1972. View

Esparza J, Purifoy D, Schaffer P, Benyesh-Melnick M . Isolation, complementation and preliminary phenotypic characterization of temperature-sensitive mutants of herpes simplex virus type 2. Virology. 1974; 57(2):554-65. DOI: 10.1016/0042-6822(74)90194-9. View

Pellegrino M, Ferrone S, Dierich M, Reisfeld R . Enhancement of sheep red blood cell human lymphocyte rosette formation by the sulfhydryl compound 2-amino ethylisothiouronium bromide. Clin Immunol Immunopathol. 1975; 3(3):324-33. DOI: 10.1016/0090-1229(75)90019-7. View

Spear P . Membrane proteins specified by herpes simplex viruses. I. Identification of four glycoprotein precursors and their products in type 1-infected cells. J Virol. 1976; 17(3):991-1008. PMC: 515499. DOI: 10.1128/JVI.17.3.991-1008.1976. View

Fauci A, Pratt K . Activation of human B lymphocytes. I. Direct plaque-forming cell assay for the measurement of polyclonal activation and antigenic stimulation of human B lymphocytes. J Exp Med. 1976; 144(3):674-84. PMC: 2190408. DOI: 10.1084/jem.144.3.674. View

Stevens R, Saxon A . Immunoregulation in humans: control of antitetanus toxoid antibody production after booster immunization. J Clin Invest. 1978; 62(6):1154-60. PMC: 371879. DOI: 10.1172/JCI109234. View

Callard R . Specific in vitro antibody response to influenza virus by human blood lymphocytes. Nature. 1979; 282(5740):734-6. DOI: 10.1038/282734a0. View

Taswell C . Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis. J Immunol. 1981; 126(4):1614-9. View

10.

Pereira L, Klassen T, Baringer J . Type-common and type-specific monoclonal antibody to herpes simplex virus type 1. Infect Immun. 1980; 29(2):724-32. PMC: 551186. DOI: 10.1128/iai.29.2.724-732.1980. View

11.

Yarchoan R, Murphy B, Strober W, SCHNEIDER H, Nelson D . Specific anti-influenza virus antibody production in vitro by human peripheral blood mononuclear cells. J Immunol. 1981; 127(6):2588-94. View

12.

Souhami R, Babbage J, Callard R . Specific in vitro antibody response to varicella zoster. Clin Exp Immunol. 1981; 46(1):98-105. PMC: 1536340. View

13.

UytdeHaag F, Osterhaus A, Loggen H, Bakker R, van Asten J, Kreeftenberg J . Induction of antigen-specific antibody response in human peripheral blood lymphocytes in vitro by a dog kidney cell vaccine against rabies virus (DKCV). J Immunol. 1983; 131(3):1234-9. View

14.

Yarchoan R, Nelson D . Specificity of in vitro anti-influenza virus antibody production by human lymphocytes: analysis of original antigenic sin by limiting dilution cultures. J Immunol. 1984; 132(2):928-35. View

15.

Yasukawa M, Zarling J . Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. I. Lysis restricted by HLA class II MB and DR antigens. J Immunol. 1984; 133(1):422-7. View

16.

Yasukawa M, Zarling J . Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. II. Bifunctional clones with cytotoxic and virus-induced proliferative activities exhibit herpes simplex virus type 1 and 2 specific or type common reactivities. J Immunol. 1984; 133(5):2736-42. View

17.

Yasukawa M, Zarling J . Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. III. Analysis of viral glycoproteins recognized by CTL clones by using recombinant herpes simplex viruses. J Immunol. 1985; 134(4):2679-82. View

18.

Misiti J, Dasch G . In vitro antigen-specific antibody response to the species-specific surface protein antigens of typhus group rickettsiae by human peripheral blood mononuclear cells: generation of an antigen-dependent suppressor T cell. J Immunol. 1985; 134(4):2689-94. View

19.

Fischer A, Sterkers G, Charron D, Durandy A . HLA class II restriction governing cell cooperation between antigen-specific helper T lymphocytes, B lymphocytes and monocytes for in vitro antibody production to influenza virus. Eur J Immunol. 1985; 15(6):620-6. DOI: 10.1002/eji.1830150617. View

20.

UytdeHaag F, Loggen H, Logtenberg T, Lichtveld R, van Steenis B, van Asten J . Human peripheral blood lymphocytes from recently vaccinated individuals produce both type-specific and intertypic cross-reacting neutralizing antibody on in vitro stimulation with one type of poliovirus. J Immunol. 1985; 135(5):3094-101. View